NEW YORK, Jan 17 (Reuters) - New Jersey’s attorney general said on Thursday she has subpoenaed Amgen Inc (AMGN.O: Quote, Profile, Research) regarding allegations that the biotechnology company promoted its rheumatoid arthritis and psoriasis drug Enbrel for unapproved uses.
